Keep a sealed dry research-peptide vial at the supplier's stated temperature. When no storage instruction is available, about -20 C or colder is a common long-term starting point for a lyophilized vial. After liquid has been added, keep the reconstituted vial at 2-8 C. A few hours at an ordinary indoor temperature of 20-25 C usually calls for putting the vial back in the refrigerator. After an overnight exposure, use a fresh vial when you need confidence that the peptide amount has not changed or that bacteria and fungi have not entered or grown. Several warm days, direct sun, or temperatures above 30 C call for replacement unless published stability data cover that exact peptide formulation.
| Storage situation | Practical decision |
|---|---|
| Sealed dry vial | Follow the supplier's storage instruction. If none is available, use about -20 C or colder as the long-term starting point. |
| Reconstituted vial | Refrigerate at 2-8 C unless the exact peptide formulation has a different tested condition. |
| A few hours at 20-25 C | Put it back in the refrigerator. A brief indoor excursion usually does not justify discarding the vial. |
| Overnight at 20-25 C | Put it back in the refrigerator. Use a fresh vial when you need confidence in the original peptide amount or freedom from contamination. |
| Several days at room temperature | Replace it unless stability data cover the same peptide, concentration, diluent, container and temperature. |
| Above 30 C, direct sun or a hot vehicle | Treat it as heat exposure. Replace it unless the exact product has supporting excursion data. |
| The liquid still looks clear | Appearance cannot confirm how much peptide remains or whether bacteria or fungi are present. |
Dry vials
Lyophilization removes most of the water and leaves the familiar dry cake or powder in the vial. Many peptide suppliers ship sealed lyophilized vials at ambient temperature because a short trip through ordinary indoor conditions is different from keeping the vial on a shelf for weeks or months. Why Lyophilized Peptides Are Supplied Dry explains that process in more detail.
Once the vial arrives, move it to the temperature stated by the supplier. About -20 C or colder is a common long-term default when no specific instruction is available. Keep the vial sealed, dry and protected from light, and allow a frozen sealed vial to warm before opening so moisture from the room does not condense inside it.
A cracked vial, loose cap, damaged stopper, unexpected moisture or leakage changes the decision. Set that vial aside and contact the supplier, because a freezer or refrigerator cannot compensate for a damaged seal.
After reconstitution
Reconstitution means adding a liquid to the dry peptide. Water gives the peptide more freedom to move and interact, which can allow oxidation, hydrolysis, aggregation and loss onto the glass or stopper surface. Handling can also introduce microorganisms. Refrigeration slows many of these processes, so 2-8 C is the general near-term condition when the exact preparation has no different tested storage instruction.
A broad peptide-handling guide from MilliporeSigma describes peptide solutions as generally stable for up to one week at about 4 C, while noting that the peptide sequence can shorten that period. That makes one refrigerated week a cautious general starting point when no better information exists. It is not a promise that every peptide fails on day eight, and it does not support keeping every mixture for several weeks. Longer storage needs evidence for the exact peptide, concentration, liquid, container and handling conditions.
Returning a warm vial to the refrigerator slows further change; it cannot reverse change that occurred while the vial was warm. Remember how long it was left out when deciding whether to keep it, because refrigeration does not reset the storage timeline.
A few hours, overnight and several days
An ordinary room is roughly 20-25 C. Peptide solutions do not all fail after the same number of minutes because their sequences, concentrations, liquids and containers differ. Official peptide formulations range from immediate use after mixing to seven days at room temperature, which gives us useful boundaries for interpreting an accidental excursion without inventing one universal shelf life.
A few hours on an indoor counter is a brief excursion. Put the vial back at 2-8 C. Most short indoor excursions do not erase all of the peptide content, although a fresh vial removes the uncertainty when you need the amount to remain as close as possible to what was originally present.
An overnight vial has spent too long outside the normal refrigerated condition to call the interval routine. Some peptides may retain much of their original content, while others can change faster. Put it back in the refrigerator, and choose a fresh vial when you need to know that the original peptide amount has been preserved or that bacteria and fungi have not entered or grown. Keeping the exposed vial does not erase the warm night from its storage history.
Several days at room temperature fall outside a defensible general storage rule. Keep that vial only when stability data cover the same peptide, concentration, diluent, container and temperature. Without that evidence, replacement gives you a dependable starting point again.
Temperatures above 30 C need a stricter decision. Direct sunlight, a radiator, a parcel left in summer heat and a parked vehicle can become much hotter than an indoor room. Replace a reconstituted vial after that kind of heat exposure unless the exact product has excursion data covering the recorded temperature and duration.
The complete formulation sets the storage time
The same peptide can have very different storage instructions when its concentration, added liquid, supporting ingredients or container changes. Tesamorelin gives an unusually clear example. EGRIFTA SV is prepared with its supplied preservative-free Sterile Water for Injection and is used immediately, while EGRIFTA WR is prepared with its supplied Bacteriostatic Water for Injection and can be stored at 20-25 C for seven days. Those products contain the same named peptide but use different strengths, ingredients and presentations.
Somatropin shows the same effect. The single-use SEROSTIM presentation prepared with sterile water is intended for immediate use. Its labelled multidose presentation prepared with bacteriostatic water can be refrigerated at 2-8 C for up to 14 days. FUZEON, an enfuvirtide presentation made with preservative-free sterile water, is used immediately or refrigerated for up to 24 hours.
| Official peptide presentation | Supplied liquid | Labelled storage after mixing |
|---|---|---|
| EGRIFTA SV (tesamorelin) | Sterile Water for Injection | Use immediately; do not refrigerate or freeze the mixed solution. |
| EGRIFTA WR (tesamorelin) | Bacteriostatic Water for Injection | Store at 20-25 C and discard after seven days; do not freeze. |
| SEROSTIM (somatropin), single-use | Sterile Water for Injection | Use immediately. |
| SEROSTIM (somatropin), multidose | Bacteriostatic Water with 0.9% benzyl alcohol | Refrigerate at 2-8 C for up to 14 days. |
| FUZEON (enfuvirtide) | Preservative-free Sterile Water for Injection | Use immediately or refrigerate at 2-8 C for up to 24 hours. |
These examples explain why the liquid and the rest of the formulation cannot be separated from the storage time. They demonstrate tested differences rather than supplying a storage period for every separately sourced peptide vial.
The 28-day bacteriostatic-water convention
Bacteriostatic water commonly contains 0.9% benzyl alcohol. The preservative helps limit the growth of some bacteria in the original multidose water vial and in preparations designed to use it. It cannot remove contamination that has already entered a vial, and it does not stop peptide oxidation, hydrolysis, aggregation or loss onto the container surface.
The familiar 28-day convention applies to an opened multidose vial of bacteriostatic water unless its manufacturer gives another period. Adding that water to a peptide creates a new mixture with its own stability. The 28-day date on the water therefore cannot be copied onto the reconstituted peptide vial. How to Store Bacteriostatic Water covers the original water vial separately.
Preservative-free sterile water contributes no continuing antimicrobial preservative after mixing. Some official peptide products made with sterile water are used immediately, while FUZEON permits refrigerated storage for up to 24 hours. The supplied liquid influences the storage window, but the complete peptide formulation and its testing establish the actual time.
Saline adds sodium chloride as well as water, so it changes the salt concentration around the peptide. That change can help one peptide remain dissolved while causing another to aggregate or precipitate, especially when the pH and concentration also differ. Check the saline label separately for sodium chloride strength and for any preservative, because the word saline alone does not identify the whole formulation or provide a storage period.
Ready-to-use pharmacy products use different formulations
Ready-to-use MOUNJARO (tirzepatide) and OZEMPIC (semaglutide) are manufactured liquid products. Canadian product information allows MOUNJARO pens or vials to remain below 30 C for up to 21 days and an in-use OZEMPIC pen to remain below 30 C for eight weeks. Their manufacturers selected the liquid ingredients, concentration, container and closure, then tested the complete packaged product under those conditions.
A lyophilized peptide vial mixed later with bacteriostatic water, sterile water, saline or another liquid is a different formulation. The pharmacy-product room-temperature periods cannot be transferred to that vial. They show that tirzepatide and semaglutide can remain stable in specific manufactured liquids; they do not establish the storage life of every mixture containing the same peptide name.
Refrigeration, freezing and repeated temperature changes
Use 2-8 C for a reconstituted peptide when no exact storage data provides another condition. Keep the vial protected from unnecessary light and movement, and avoid repeatedly moving it between cold and warm environments. Every warm interval becomes part of that vial's storage history.
Freezing can extend the useful life of some peptide solutions, but other formulations can aggregate, precipitate or lose material during freezing and thawing. Repeated freeze-thaw cycles add further stress. Freeze a reconstituted vial only when the supplier or a stability source covers the same peptide, concentration, liquid and container; otherwise, refrigeration is the clearer general choice.
Dry lyophilized vials are different. Freezer storage around -20 C or colder is a common long-term condition for sealed dry peptides, while freezing a vial after liquid has been added needs formulation-specific support.
Visible warning signs and invisible changes
Set aside a vial with cloudiness, unexpected particles, colour change, leakage, damaged glass or a compromised stopper, then contact the supplier. Those signs show that the vial no longer looks as expected.
A clear vial only tells you that those visible changes are absent. Peptide content can fall through chemical breakdown or by sticking to the container without producing a visible change, and microbial contamination may also be invisible. Appearance cannot confirm the peptide's concentration, purity or microbial condition after a storage excursion.
For a peptide with no more specific storage sheet, the practical path is consistent: keep the sealed dry vial around -20 C or colder for long-term storage, refrigerate the reconstituted vial at 2-8 C, and use one refrigerated week as a cautious general starting point rather than borrowing the 28-day BAC-water convention. A few indoor hours usually lead back to refrigeration, an overnight vial calls for a fresh replacement when you need confidence in the original peptide amount or freedom from contamination, and several warm days or high heat call for replacement unless the exact formulation has evidence supporting that exposure.
Sources and context
The storage periods named for EGRIFTA SV, EGRIFTA WR, SEROSTIM, FUZEON, MOUNJARO and OZEMPIC come from their official product information. They demonstrate how much the complete formulation can change a storage window and do not set storage instructions for separately sourced peptide vials.
- EGRIFTA SV - DailyMed label
- EGRIFTA WR - DailyMed label
- SEROSTIM - DailyMed label
- FUZEON - FDA label
- MOUNJARO - Health Canada product monograph
- OZEMPIC - Health Canada product monograph
General handling guidance and the explanation of chemical change, aggregation, adsorption and contamination draw on the following supplier, public-health and peer-reviewed sources.
- Thermo Fisher Scientific - Custom Peptide Storage and Dissolution
- MilliporeSigma - Handling and Storage Guidelines for Peptides and Proteins
- CDC - Preventing Unsafe Injection Practices
- Alqahtani et al. - Designing Formulation Strategies for Enhanced Stability of Therapeutic Peptides in Aqueous Solutions
- Zapadka et al. - Factors Affecting the Physical Stability of Peptide Therapeutics
- Malgave et al. - Influence of Buffering Capacity, pH and Temperature on the Stability of Semaglutide
Research-use notice: Precision Synthetics Canada products and documentation are provided strictly for lawful, non-clinical laboratory research purposes only. COAs and testing records are not medical documents, safety guarantees, sterility guarantees, therapeutic endorsements, dosing guidance, or approval for human or veterinary use.